Chronic obstructive pulmonary disease case finding by community pharmacists: A potential cost-effective public health intervention

International Journal of Pharmacy Practice

Volumn 23, Issue 1, 2015, Pages 83-85

  Wright, David ^a   Twigg, Michael ^a   Thornley, Tracey ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b The Boots Company PLC   (United Kingdom)

Author keywords

community pharmacy; COPD; cost effectiveness; health promotion; pharmaceutical public health

Indexed keywords

ALCOHOL;

ADULT; ARTICLE; CASE FINDING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIETARY INTAKE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; NUTRITION; PHARMACY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; RISK FACTOR; SMOKING; SMOKING CESSATION; UNITED KINGDOM; WEIGHT; COST BENEFIT ANALYSIS; ECONOMICS; ENGLAND; FEMALE; MALE; MIDDLE AGED; PILOT STUDY;

ADULT; COMMUNITY PHARMACY SERVICES; COST-BENEFIT ANALYSIS; ENGLAND; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY-ADJUSTED LIFE YEARS; SMOKING CESSATION;

EID: 84922439705     PISSN: 09617671     EISSN: 20427174     Source Type: Journal    
DOI: 10.1111/ijpp.12161     Document Type: Article

References (9)

1. British Thoracic Society. The Burden of Lung Disease: A Statistics Report from the British Thoracic Society, 2nd edn. London: British Thoracic Society, 2006.
2. NHS Medical Directorate. COPD Commissioning Toolkit. A Resource for Commissioners. London, 2012.
3. British Lung Foundation. Invisible Lives: Chronic Obstructive Pulmonary Disease (COPD) Finding the Missing Millions. London: British Lung Foundation, 2007.
4. Martinez FJ et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD 2008; 5: 85-95.
5. Global Initiative for Chronic Obstructive Lung Disease (2013) Global Strategy for the Diagnosis,Management and Prevention of Chronic Obstructive Pulmonary Disease. Updated. http://www .goldcopd.org/ (accessed 30 October 2014).
6. Falzon C et al. Finding the missing millions the impact of a locally enhanced service for COPD on current and projected rates of diagnosis: a populationbased prevalence study using interrupted time series analysis. Prim Care Respir J 2013; 22: 59-63.
7. Castillo D et al. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study. RespirMed 2009; 103: 839845.
8. Atsou K et al. Simulation-based estimates of effectiveness and costeffectiveness of smoking cessation in patients with chronic bstructive pulmonary disease. PLoS ONE 2011; 6: e24870.
9. Britton M. The burden of COPD in the U.K.: results from the confronting COPD survey. Respir Med 2003; 97(Suppl. C): S71S79.